DS
CABA icon

David Shaw’s Cabaletta Bio CABA Stock Holding History

David Shaw’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Sell
90,652
-98,760
-52% -$325K ﹤0.01% 4439
2026
Q1 		$510K Buy
+189,412
New +$526K ﹤0.01% 3851
2025
Q1 		– Sell
-16,604
Closed -$37.7K – 4283
2024
Q4 		$37.7K Sell
16,604
-17,359
-51% -$60.9K ﹤0.01% 4210
2024
Q3 		$160K Buy
+33,963
New +$197K ﹤0.01% 4194
2024
Q2 		– Sell
-16,111
Closed -$275K – 4502
2024
Q1 		$275K Buy
+16,111
New +$346K ﹤0.01% 3776

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

David Shaw's CABA Position: Q2 2026 in Review

David Shaw reduced its Cabaletta Bio (CABA) stake by 52% in Q2 2026, selling an estimated $325K and leaving 90,652 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #4439.

David Shaw first reported a position in CABA in Q1 2024 and has held it in 5 quarters since. The position peaked at $510K in Q1 2026. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • David Shaw held 90,652 shares of Cabaletta Bio worth $282K as of Q2 2026.
  • David Shaw sold 98,760 Cabaletta Bio shares in Q2 2026, an estimated $325K.
  • Cabaletta Bio made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4439 holding.
  • David Shaw first reported a position in Cabaletta Bio in Q1 2024 and has held it in 5 quarters since.
  • David Shaw's Cabaletta Bio position peaked at $510K in Q1 2026.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.